Literature DB >> 6679873

Bioenergetics of intact human muscle. A 31P nuclear magnetic resonance study.

D J Taylor, P J Bore, P Styles, D G Gadian, G K Radda.   

Abstract

The metabolic state of human muscle in various functional states has been investigated by the non-invasive technique of 31P nuclear magnetic resonance. The concentrations of phosphocreatine, ATP and inorganic phosphate as well as intracellular pH in the flexor digitorum superficialis have been measured during rest, dynamic exercise and recovery from exercise. The observed relationship between phosphocreatine utilization and decrease in intracellular pH during aerobic exercise indicates that lactate production only becomes significant after more than 60% of the phosphocreatine is used up. Surprisingly intracellular pH may reach as low a value as 5.9 to 6.1, indicating that phosphofructokinase is still partially active at pH 6.0. There is no metabolic recovery if the muscle is made ischaemic following exercise, implying that glycolysis is switched off as soon as exercise is stopped. Lactic acidosis is not the cause of this and presumably Ca2+ is needed to maintain the activation of phosphorylase kinase. The time-course of phosphocreatine recovery after exercise reflects the rate of oxidative metabolism, while pH recovery probably represents H+ ion export from the muscle cell. The dynamics of metabolic changes can now be observed with a time resolution of 10 to 60 seconds and thus disturbances in energy metabolism can be readily detected in several pathological states.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6679873

Source DB:  PubMed          Journal:  Mol Biol Med        ISSN: 0735-1313


  151 in total

Review 1.  The relationship between aerobic fitness and recovery from high intensity intermittent exercise.

Authors:  D L Tomlin; H A Wenger
Journal:  Sports Med       Date:  2001       Impact factor: 11.136

2.  Oxidative capacity and ageing in human muscle.

Authors:  K E Conley; S A Jubrias; P C Esselman
Journal:  J Physiol       Date:  2000-07-01       Impact factor: 5.182

3.  Parameter estimation in modeling phosphocreatine recovery in human skeletal muscle.

Authors:  Laurent M Arsac; Eric Thiaudière; Philippe Diolez; Léo Gerville-Réache
Journal:  Eur J Appl Physiol       Date:  2003-11-19       Impact factor: 3.078

Review 4.  Influence of racial origin and skeletal muscle properties on disease prevalence and physical performance.

Authors:  Richard R Suminski; Craig O Mattern; Steven T Devor
Journal:  Sports Med       Date:  2002       Impact factor: 11.136

5.  Phosphorus-31 nuclear magnetic resonance study on the effects of endurance training in rat skeletal muscle.

Authors:  S Y Kuno; M Akisada; F Mitsumori
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1992

6.  Influence of passive lower-body heating on muscle metabolic perturbation and high-intensity exercise tolerance in humans.

Authors:  Stephen J Bailey; Daryl P Wilkerson; Jonathan Fulford; Andrew M Jones
Journal:  Eur J Appl Physiol       Date:  2012-02-10       Impact factor: 3.078

Review 7.  Factors affecting the rate of phosphocreatine resynthesis following intense exercise.

Authors:  Shaun McMahon; David Jenkins
Journal:  Sports Med       Date:  2002       Impact factor: 11.136

8.  Acidosis inhibits oxidative phosphorylation in contracting human skeletal muscle in vivo.

Authors:  Sharon A Jubrias; Gregory J Crowther; Eric G Shankland; Rodney K Gronka; Kevin E Conley
Journal:  J Physiol       Date:  2003-09-26       Impact factor: 5.182

9.  Vitamin-responsive complex I deficiency in a myopathic patient with increased activity of the terminal respiratory chain and lactic acidosis.

Authors:  H D Bakker; H R Scholte; J A Jeneson; H F Busch; N G Abeling; A H van Gennip
Journal:  J Inherit Metab Dis       Date:  1994       Impact factor: 4.982

10.  Dynamic phosphocreatine imaging with unlocalized pH assessment of the human lower leg muscle following exercise at 3T.

Authors:  Oleksandr Khegai; Guillaume Madelin; Ryan Brown; Prodromos Parasoglou
Journal:  Magn Reson Med       Date:  2017-05-30       Impact factor: 4.668

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.